Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety.

Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Original language	English
Pages (from-to)	365-372
Journal	Wiener medizinische Wochenschrift
Volume	172
Issue number	15-16
DOIs	https://doi.org/10.1007/s10354-022-00931-4
Publication status	Published - 2022

Keywords

@article{ce2e392b79964e6ebfd72f2ec83e42da,

title = "Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety.",

keywords = "ORAL CLADRIBINE, MS",

author = "Tobias Moser and Tjalf Ziemssen and Johann Sellner",

note = "Moser, Tobias: Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1007/s10354-022-00931-4",

language = "English",

volume = "172",

pages = "365--372",

journal = "Wiener medizinische Wochenschrift",

issn = "0043-5341",

publisher = "Springer Nature",

number = "15-16",

}

TY - JOUR

T1 - Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety.

AU - Moser, Tobias

AU - Ziemssen, Tjalf

AU - Sellner, Johann

N1 - Moser, Tobias: Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - ORAL CLADRIBINE

KW - MS

U2 - 10.1007/s10354-022-00931-4

DO - 10.1007/s10354-022-00931-4

M3 - Original Article

C2 - 35451662

SN - 0043-5341

VL - 172

SP - 365

EP - 372

JO - Wiener medizinische Wochenschrift

JF - Wiener medizinische Wochenschrift

IS - 15-16

ER -